Emily Anne Ferenczi, B.M.,B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalomalacia | 1 | 2018 | 17 | 0.630 |
Why?
|
| Delusions | 1 | 2020 | 296 | 0.600 |
Why?
|
| Frontotemporal Dementia | 1 | 2020 | 243 | 0.570 |
Why?
|
| Face | 1 | 2022 | 1010 | 0.530 |
Why?
|
| Lighting | 1 | 2016 | 210 | 0.460 |
Why?
|
| Ion Pumps | 1 | 2012 | 15 | 0.430 |
Why?
|
| Corpus Striatum | 1 | 2016 | 1220 | 0.340 |
Why?
|
| Neurons | 6 | 2018 | 9292 | 0.340 |
Why?
|
| Reward | 1 | 2016 | 935 | 0.330 |
Why?
|
| Neural Inhibition | 1 | 2012 | 585 | 0.310 |
Why?
|
| Receptors, GABA-A | 1 | 2012 | 624 | 0.300 |
Why?
|
| Ammonia | 1 | 2008 | 233 | 0.290 |
Why?
|
| Prefrontal Cortex | 3 | 2016 | 2176 | 0.280 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 461 | 0.280 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1161 | 0.270 |
Why?
|
| Motivation | 1 | 2016 | 1966 | 0.260 |
Why?
|
| Psychotic Disorders | 1 | 2020 | 3099 | 0.250 |
Why?
|
| Neural Pathways | 5 | 2016 | 3014 | 0.240 |
Why?
|
| Coma | 1 | 2008 | 483 | 0.240 |
Why?
|
| Fluid Therapy | 1 | 2007 | 584 | 0.220 |
Why?
|
| Glioblastoma | 1 | 2018 | 3462 | 0.210 |
Why?
|
| Light | 4 | 2016 | 1333 | 0.210 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2008 | 1699 | 0.200 |
Why?
|
| Facies | 1 | 2022 | 199 | 0.200 |
Why?
|
| Hippocampus | 2 | 2015 | 3687 | 0.190 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 544 | 0.180 |
Why?
|
| Opsins | 3 | 2018 | 18 | 0.180 |
Why?
|
| West Nile Fever | 2 | 2011 | 75 | 0.170 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 1753 | 0.170 |
Why?
|
| Models, Neurological | 4 | 2016 | 1748 | 0.170 |
Why?
|
| Patch-Clamp Techniques | 2 | 2016 | 937 | 0.160 |
Why?
|
| Membrane Potentials | 2 | 2016 | 1103 | 0.150 |
Why?
|
| Brain | 5 | 2017 | 26597 | 0.150 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 2142 | 0.150 |
Why?
|
| Saimiri | 1 | 2018 | 334 | 0.150 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 8856 | 0.140 |
Why?
|
| Rats, Inbred LEC | 1 | 2016 | 2 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 3118 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3272 | 0.130 |
Why?
|
| Implants, Experimental | 1 | 2015 | 103 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1825 | 0.130 |
Why?
|
| Nerve Net | 2 | 2018 | 2212 | 0.120 |
Why?
|
| Wireless Technology | 1 | 2015 | 97 | 0.120 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 47 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2016 | 569 | 0.120 |
Why?
|
| Mesencephalon | 1 | 2016 | 327 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 2017 | 969 | 0.110 |
Why?
|
| Diet | 1 | 2010 | 7888 | 0.100 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2012 | 54 | 0.100 |
Why?
|
| Xenopus laevis | 1 | 2016 | 962 | 0.100 |
Why?
|
| Neocortex | 1 | 2015 | 409 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9107 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 2505 | 0.100 |
Why?
|
| Dopamine | 2 | 2016 | 1572 | 0.100 |
Why?
|
| Oocytes | 1 | 2016 | 1174 | 0.090 |
Why?
|
| Dentate Gyrus | 1 | 2012 | 161 | 0.090 |
Why?
|
| Horse Diseases | 1 | 2011 | 54 | 0.090 |
Why?
|
| West Nile virus | 1 | 2011 | 78 | 0.090 |
Why?
|
| Protons | 1 | 2016 | 1116 | 0.090 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 1730 | 0.090 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2018 | 1020 | 0.090 |
Why?
|
| Axons | 2 | 2018 | 1663 | 0.090 |
Why?
|
| Fear | 2 | 2015 | 1440 | 0.090 |
Why?
|
| tau Proteins | 1 | 2020 | 2013 | 0.090 |
Why?
|
| Corpus Callosum | 1 | 2014 | 729 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 488 | 0.080 |
Why?
|
| Animals | 15 | 2018 | 166558 | 0.080 |
Why?
|
| Fast Foods | 1 | 2010 | 204 | 0.080 |
Why?
|
| Amygdala | 1 | 2015 | 1329 | 0.080 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2008 | 229 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 8131 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2015 | 1774 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 11658 | 0.070 |
Why?
|
| Myocardial Reperfusion | 1 | 2008 | 345 | 0.070 |
Why?
|
| Heart Failure, Systolic | 1 | 2008 | 130 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4182 | 0.070 |
Why?
|
| Myotonic Dystrophy | 1 | 2006 | 78 | 0.070 |
Why?
|
| Lipids | 1 | 2017 | 3290 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 21600 | 0.070 |
Why?
|
| Memory | 1 | 2015 | 2168 | 0.060 |
Why?
|
| Professional Practice | 1 | 2007 | 311 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 15319 | 0.060 |
Why?
|
| Humans | 17 | 2022 | 746630 | 0.060 |
Why?
|
| Rana temporaria | 1 | 2003 | 4 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2018 | 3072 | 0.060 |
Why?
|
| Rats | 3 | 2016 | 23696 | 0.060 |
Why?
|
| Oxygen | 1 | 2016 | 4182 | 0.060 |
Why?
|
| Hypertonic Solutions | 1 | 2003 | 84 | 0.060 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2009 | 780 | 0.060 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2003 | 101 | 0.060 |
Why?
|
| Hand Strength | 1 | 2006 | 450 | 0.060 |
Why?
|
| Video Recording | 1 | 2008 | 944 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1376 | 0.050 |
Why?
|
| Calcium | 1 | 2016 | 5656 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2016 | 3744 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2010 | 1168 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 664 | 0.050 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2003 | 136 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2010 | 1981 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2229 | 0.050 |
Why?
|
| Proteins | 1 | 2017 | 6007 | 0.050 |
Why?
|
| Male | 12 | 2018 | 351420 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 617 | 0.050 |
Why?
|
| Medical Records | 1 | 2007 | 1391 | 0.050 |
Why?
|
| Calibration | 1 | 2003 | 801 | 0.050 |
Why?
|
| Kinetics | 2 | 2011 | 6361 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2003 | 475 | 0.050 |
Why?
|
| Anxiety | 1 | 2015 | 4409 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 1866 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2003 | 1267 | 0.050 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 1435 | 0.050 |
Why?
|
| Brain Mapping | 1 | 2016 | 6598 | 0.040 |
Why?
|
| Hungary | 2 | 2011 | 82 | 0.040 |
Why?
|
| Female | 11 | 2020 | 382450 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2008 | 8902 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 35797 | 0.040 |
Why?
|
| Risk Factors | 3 | 2018 | 72447 | 0.040 |
Why?
|
| Life Style | 1 | 2010 | 3823 | 0.040 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2008 | 1403 | 0.040 |
Why?
|
| Mice | 5 | 2017 | 80251 | 0.040 |
Why?
|
| Sodium | 1 | 2003 | 1605 | 0.040 |
Why?
|
| Risk | 1 | 2010 | 9522 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 5717 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2008 | 2587 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6460 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 1973 | 0.040 |
Why?
|
| Middle Aged | 5 | 2020 | 214618 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2016 | 6838 | 0.040 |
Why?
|
| Time Factors | 2 | 2016 | 39622 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11384 | 0.040 |
Why?
|
| Body Weight | 1 | 2007 | 4606 | 0.030 |
Why?
|
| Stents | 1 | 2008 | 3282 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10750 | 0.030 |
Why?
|
| Learning | 2 | 2015 | 1719 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2017 | 239 | 0.030 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2015 | 41 | 0.030 |
Why?
|
| Miniaturization | 1 | 2015 | 156 | 0.030 |
Why?
|
| Electromagnetic Phenomena | 1 | 2016 | 161 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2010 | 10096 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 12044 | 0.030 |
Why?
|
| Depression | 1 | 2012 | 7826 | 0.030 |
Why?
|
| Dependovirus | 1 | 2018 | 701 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3699 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12840 | 0.030 |
Why?
|
| Halorhodopsins | 1 | 2012 | 9 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2008 | 8405 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2008 | 57586 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2012 | 32 | 0.030 |
Why?
|
| Extinction, Psychological | 1 | 2015 | 369 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 9513 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 372 | 0.030 |
Why?
|
| Thalamus | 1 | 2018 | 1010 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 2015 | 466 | 0.020 |
Why?
|
| Nociceptors | 1 | 2015 | 449 | 0.020 |
Why?
|
| Ventral Tegmental Area | 1 | 2012 | 135 | 0.020 |
Why?
|
| Microinjections | 1 | 2012 | 322 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2012 | 321 | 0.020 |
Why?
|
| Biophysics | 1 | 2012 | 382 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2012 | 310 | 0.020 |
Why?
|
| Horses | 1 | 2011 | 295 | 0.020 |
Why?
|
| Somatosensory Cortex | 1 | 2014 | 519 | 0.020 |
Why?
|
| Nucleus Accumbens | 1 | 2012 | 358 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 7229 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 471 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 2011 | 364 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 1101 | 0.020 |
Why?
|
| Stress, Psychological | 2 | 2015 | 4305 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2015 | 1407 | 0.020 |
Why?
|
| Temperature | 1 | 2015 | 2196 | 0.020 |
Why?
|
| AIDS Serodiagnosis | 1 | 2009 | 210 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 453 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 1857 | 0.020 |
Why?
|
| Hypertension | 1 | 2008 | 8366 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2015 | 981 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2010 | 63732 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 3510 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2008 | 23464 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2012 | 1729 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 38771 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3743 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2657 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2012 | 1008 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2011 | 1508 | 0.020 |
Why?
|
| Heart Failure | 1 | 2010 | 11096 | 0.020 |
Why?
|
| Action Potentials | 1 | 2011 | 1773 | 0.010 |
Why?
|
| Phylogeny | 1 | 2011 | 2736 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2006 | 588 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 2006 | 409 | 0.010 |
Why?
|
| HIV Infections | 1 | 2009 | 16936 | 0.010 |
Why?
|
| Observer Variation | 1 | 2008 | 2574 | 0.010 |
Why?
|
| Health Resources | 1 | 2008 | 906 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2011 | 3074 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4879 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4399 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 2057 | 0.010 |
Why?
|
| Aged | 2 | 2007 | 164383 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5467 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2008 | 3190 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16261 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9124 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14543 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2008 | 4678 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10284 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 20820 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15555 | 0.010 |
Why?
|
| Adult | 2 | 2009 | 215192 | 0.000 |
Why?
|